Veradigm | Zahlungsmittel Und Äquivalente

Aktienkurs
4.30
Täglich Wechseln
-0.20 -4.44%
Monatlich
-9.47%
Jährlich
-19.63%
Q1 Prognose
7.75




Zahlungsmittel Und Äquivalente Veränderung Datum
Alcidion AUD 11.8M 2.84M 2024-06
Ambu A/S DKK 735M 16M 2025-12
Amplifon EUR 237.31M 5.38M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Centene USD 17.89B 830M 2025-12
Charles River Laboratories USD 207.1M 24.27M 2025-09
Cigna USD 6.02B 1.7B 2025-09
Convatec Group USD 64.7M 32.2M 2024-12
CVS Health USD 8.45B 645M 2025-12
Diasorin EUR 173.08M 3.51M 2025-06
Elevance Health USD 9.49B 778M 2025-12
General Electric Aerospace USD 12.39B 109M 2025-12
Gulf Medical Proj AED 74.52M 101.52M 2025-03
Humana USD 4.2B 1.19B 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 598.1M 49.2M 2025-09
Maximus USD 137.59M 84.76M 2025-12
McKesson USD 2.96B 1.05B 2025-12
Med Life RON 149.56M 36.59M 2025-06
Molina Healthcare USD 4.25B 27M 2025-12
Omnicell USD 180.05M 218.95M 2025-09
Oriola-kd EUR 107.6M 13.9M 2025-09
Owens Minor USD 32.84M 5.42M 2025-09
Quest Diagnostics USD 420M 12M 2025-12
Rede D'or Sao Luiz BRL 5.53B 456.83M 2025-09
Siemens Healthineers EUR 2.37B 30M 2025-06
Sonova Holding CHF 413.9M 134.3M 2023-06
Supermax Corporation Bhd MYR 855.25M 11.02M 2025-09
UnitedHealth USD 28.12B 2.49B 2025-12
Veeva Systems USD 1.66B 270.29M 2025-09
Veradigm USD 492.6M 7.57M 2022-09
Xerox USD 479M 30M 2025-09


Veradigm Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.